Author:
Pastore D.,Specchia G.,Carluccio P.,Liso A.,Mestice A.,Rizzi R.,Greco G.,Buquicchio C.,Liso V.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference31 articles.
1. Angelov L, Brandwein J, Baker M (1991) Results of therapy for acute myeloid leukemia in first relapse. Leuk Lymphoma 6:15–24
2. Bassan R, Lerede T, Buelli M, Boleri G, Bellavita P, Rambaldi A, Barbui T (1998) A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia. Hematologica 83:422–427
3. Bennet JM, Catowsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620–625
4. Berman E, Heller G, Santorsa J, McKenzie S, Gee T, Kempin S, Gulati S, Andreeff M, Kolitz J, Gabrilove J (1991) Results of randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myeloid leukemia. Blood 77:1666–1671
5. Carella AM, Carlier P, Pungolino E, Resegotti L, Liso V, Stasi R, Montillo M, Iacopino P, Mirto S, Pagano L (1993) Idarubicin in combination with intermediate dose of cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group. Leukemia 7:196
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献